Drug maker Lee's Pharmaceutical hits 6-month high on strong forecast

Lees Pharmaceutical Holdings

05/03/2019 02:57

** Shares of Lee's Pharmaceutical Holdings Ltd  0950.HK 
rise as much as 5.4 pct to HK$7.16, the highest since Sept. 7,
2018, after co forecasts strong growth in 2018 earnings 
    ** Co anticipates 2018 net profit to rise about 50 pct from
a year ago amid a non-recurring gain from sale of interests in
Taiwan-based cardiovascular disease drugs developer, CVie
Therapeutics Ltd, in December 2018  urn:newsml:reuters.com:*:nFWN20R0AF
    ** Co is due to announce its results by end March
    ** As of last close, the stock had risen 23.5 pct so far
this year
    ** Lee's Pharmaceutical has outperformed the Hang Seng
Commerce & Industry Index sector  .HSNC  by 6.3 percentage
points in the past one month
    ** The Hong Kong benchmark index  .HSI  edges down 0.2 pct

 (Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)